Results 191 to 200 of about 756,756 (215)

Diagnosis, Characteristics, and Outcome of Selective Anti-polysaccharide Antibody Deficiencies In A Retrospective Cohort of 55 Adult Patients. [PDF]

open access: yesJ Clin Immunol
Perrard N   +17 more
europepmc   +1 more source

Vaccination Coverage in Hematopoietic Stem Cell Transplant Patients. [PDF]

open access: yesVaccines (Basel)
Bouzas-Rodríguez A   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines

Expert Review of Vaccines, 2018
Introduction: Vaccination against group B Streptococcus (GBS) during pregnancy could provide protection against disease in the mother, fetus, and newborn.
Sonwabile Dzanibe, S. Madhi
semanticscholar   +1 more source

Protective efficacy of pneumococcal polysaccharide vaccines.

Journal of the American Medical Association (JAMA), 1977
Clinical studies of 6- and 12-valent pneumococcal capsular polysaccharide vaccines were carried out in controlled studies among novice gold miners in South Africa.
P. Smit   +4 more
semanticscholar   +1 more source

Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.

Journal of Infectious Diseases, 1977
During an epidemic caused by group A Neisseria meningitidis, 98,272 children (three months to five years of age) were vaccinated in three provinces of Finland. Meningococcal group A and Haemophilus influenzae type b polysaccharide vaccines were used in a
P. Mäkelä   +7 more
semanticscholar   +1 more source

Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.

Journal of Infectious Diseases, 1977
Immunization of infants three to 24 months of age with polysaccharide vaccines derived from groups A and C Neisseria meningitidis induced no significant local or systemic adverse reactions.
R. Gold   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy